cell
membran
protein
believ
play
critic
role
pathogenesi
autoimmun
diseas
howev
membran
autoantigen
link
diseas
cellchip
perform
identifi
autoantibodi
target
cell
suspect
autoantigen
detect
use
immunoblot
amino
acid
sequenc
detect
protein
determin
use
lcmalditoftof
put
protein
recombinantli
express
purifi
correspond
elisa
develop
clinic
valid
use
real
clinic
sampl
found
membran
protein
annexin
detect
approxim
onethird
patient
blood
circul
immunohistochemistri
result
show
annexin
highli
express
vascular
endotheli
cell
moreov
vascular
involv
significantli
higher
antiannexin
antibodyposit
group
versu
antiannexin
antibodyneg
group
among
clinic
sampl
analyz
indic
annexin
novel
endotheli
cell
membran
antigen
involv
diseas
open
subject
area
autoimmun
autoimmun
diseas
system
biolog
b
diseas
bd
chronic
multisystem
vascul
unknown
etiolog
diseas
global
epidemiolog
preval
region
span
east
asia
japan
korea
china
mediterranean
basin
includ
turkey
middl
eastern
countri
similar
classic
autoimmun
diseas
system
lupu
erythematosu
sle
sjogren
syndrom
ss
rheumatoid
arthriti
ra
bd
also
exhibit
divers
clinic
manifest
indic
coexist
larg
number
autoantigen
fact
effort
group
led
success
identif
autoantigen
includ
retin
santigen
irbp
atropomyosin
sbp
annexin
v
moreov
vascular
syndrom
wide
occur
bd
progress
made
research
regard
vascular
endotheli
cell
target
antigen
import
factor
pathogenesi
bd
antiendotheli
cell
antibodi
aeca
detect
bd
patient
proven
associ
vascul
symptom
thu
scientist
emphas
import
endotheli
cell
aeca
pathogenesi
bd
past
decad
aenolas
success
identifi
human
dermal
microvascular
endotheli
cell
selfantigen
bd
identifi
human
microvascular
endotheli
cell
kinectin
identifi
candid
autoantigen
bd
bovin
aortic
endotheli
cell
line
prohibitin
also
identifi
new
endotheli
cell
autoantigen
laboratori
recent
use
differ
system
biotechnolog
method
believ
combinatori
use
multipl
highthroughput
technolog
might
reveal
new
insight
basic
biolog
autoimmun
diseas
multiplex
assay
technolog
molecular
cellular
level
enabl
identif
new
biomark
find
provid
clear
inform
understand
pathogenesi
greatli
expand
current
knowledg
bd
howev
mani
question
remain
particularli
specif
selfantigen
primarili
local
cell
surfac
success
identifi
clearli
membran
protein
repres
import
group
protein
involv
commun
cell
extern
stimuli
intracellular
protein
far
like
result
injuri
tissu
primari
process
intracellular
antigen
target
autoantigen
identifi
autoimmun
diseas
membran
local
like
play
key
role
origin
process
autoimmun
diseas
trigger
autoimmun
therefor
aim
studi
identifi
cell
membran
autoantigen
bd
promis
target
screen
autoantigen
six
cell
line
cultur
develop
cellchip
use
prescreen
patient
sera
select
good
candid
cell
line
identif
membran
antigen
huvec
show
posit
bind
signal
patient
sera
confirm
presenc
aeca
bd
patient
howev
cell
also
abund
fluoresc
signal
suggest
cell
may
new
autoantibodi
target
fig
b
fluoresc
differ
fluoresc
stain
result
without
nucleu
among
six
cell
line
quantifi
use
imag
j
softwar
fig
intens
membran
stain
make
cell
line
good
candid
identif
membran
antigen
identif
new
autoantigen
elisa
membran
antigen
serum
sampl
bd
patient
investig
select
subject
contain
larg
number
aeca
five
subject
bd
patient
present
rel
higher
optic
densiti
valu
select
analysi
fig
protein
immunoblot
perform
display
put
bind
target
detect
autoantibodi
bind
antigen
observ
igg
autoantibodi
cell
antigen
detect
bd
patient
bind
signal
detect
healthi
control
fig
newli
identifi
autoantigen
cut
polyacrylamid
gel
digest
trypsin
peptid
fragment
identifi
use
lcmalditoftof
mass
spectrometri
analyz
use
mascot
bioinformat
databas
obtain
amino
acid
sequenc
detect
protein
shown
target
protein
share
signific
sequenc
homolog
annexin
estim
molecular
weightpi
ncbi
access
number
mascot
score
match
uniqu
peptid
accur
determin
confid
interv
ci
indic
credibl
result
fig
annexin
protein
new
autoantigen
bd
select
target
protein
obtain
recombin
dna
technolog
sequenc
mass
spectrometri
use
western
blot
immunoprecipit
competit
immunofluoresc
confirm
protein
real
autoantigen
bd
success
first
express
purif
recombin
human
annexin
protein
perform
fig
b
purifi
annexin
protein
confirm
use
mass
spectrometri
fig
western
blot
purifi
mous
antihuman
annexin
monoclon
antibodi
success
data
shown
second
immunoprecipit
perform
determin
whether
detect
antigen
real
autoantigen
bd
shown
fig
f
band
annexin
clearli
present
immunoprecipit
indic
annexin
inde
autoantigen
bd
present
patient
blood
circul
furthermor
competit
immunofluoresc
assay
also
use
analyz
inhibitori
activ
annexin
protein
fig
gi
shown
recombin
human
annexin
protein
could
significantli
reduc
bind
activ
bd
patient
sera
vitro
prove
antiannexin
antibodi
found
blood
circul
bd
patient
preval
antiannexin
autoantibodi
investig
role
annexin
correspond
antiannexin
elisa
develop
use
purifi
recombin
antigen
antiannexin
antibodi
detect
bd
patient
sle
patient
ss
patient
hc
reactiv
sera
igg
human
recombin
annexin
bd
patient
higher
sle
ss
appar
healthi
individu
fig
correl
analysi
annexin
antibodi
possibl
molecular
interact
annexin
process
bd
analyz
elisa
correlationship
annexin
fig
optic
densiti
obtain
sera
recombin
human
annexin
correl
recombin
human
bd
patient
r
sle
patient
r
express
local
annexin
human
tissu
immunohistochemistri
use
analyz
differ
protein
express
human
umbil
veinarteri
squamou
cell
lung
cancer
kidney
cancer
tissu
sampl
result
show
annexin
specif
express
human
umbil
vein
arteri
vascular
endotheli
cell
cell
vessel
fig
b
high
express
annexin
clearli
observ
human
squamou
cell
lung
cancer
kidney
cancer
tissu
fig
result
consist
data
western
blot
analysi
also
show
express
annexin
cell
highest
among
cell
test
follow
cell
huvec
data
shown
stain
commerci
annexin
monoclon
antibodi
human
umbil
veinarteri
tissu
fig
consist
antiannexin
antibodyposit
bd
patient
sera
put
togeth
result
show
annexin
real
aeca
autoantigen
bd
clinic
signific
bd
patient
correlationship
annexin
clinic
symptom
involv
bd
patient
analyz
among
bd
patient
subject
show
posit
reaction
recombin
human
annexin
protein
compar
clinic
inform
antiannexin
antibodyposit
neg
subject
vascular
involv
approxim
four
time
higher
antiannexin
antibodyposit
group
clinic
symptom
signific
differ
observ
detail
clinic
inform
bd
patient
analyz
summar
fig
primari
vascular
endotheli
cell
consid
origin
autoimmun
target
bd
cell
necessarili
best
candid
screen
blood
circul
autoantibodi
partli
due
cell
differenti
may
caus
variat
protein
abund
differ
situat
studi
cellchip
design
identifi
autoantibodi
target
cell
found
cell
possess
signific
bind
abil
possibl
origin
fuse
cell
line
properti
huvec
cell
annexin
phospholipidbind
protein
wide
distribut
throughout
cell
membran
involv
sever
import
biolog
process
exocytosi
endocytosi
cell
cycl
regul
immunoglobulin
transport
annexin
overexpress
describ
mani
cancer
includ
liver
lung
kidney
cancer
protein
might
play
import
role
tumor
cell
prolifer
regul
migrat
identifi
vascular
endotheli
cell
plasminogen
receptor
plasminogen
activ
cell
surfac
annexin
also
play
pivot
role
process
thrombosi
antiphospholipid
syndrom
mediat
endotheli
cell
activ
glycoprotein
antibodi
furthermor
deregul
annexin
express
acut
promyelocyt
leukemia
import
mechan
bleed
diathesi
recent
studi
indic
annexin
may
target
autoantibodi
sle
ss
ra
system
vascul
hypothes
antiannexin
antibodi
induc
thrombosi
activ
endotheli
cell
inhibit
plasmin
gener
furthermor
anoth
member
annexin
alreadi
describ
serum
antiannexin
v
antibodi
significantli
higher
neurobd
patient
compar
without
homolog
analysi
indic
amino
acid
sequenc
human
annexin
protein
ident
annexin
v
result
relat
reactiv
antiannexin
studi
annexin
suggest
novel
membran
autoantigen
bd
may
involv
process
capillari
injuri
bd
process
compar
clinic
inform
antiannexin
antibodyposit
andneg
group
vascular
involv
four
time
higher
antiannexin
antibodyposit
group
indic
annexin
may
close
relationship
vascular
inflamm
damag
number
studi
shown
annexin
play
role
pathogen
receptor
research
believ
bd
relat
infect
microorgan
sometim
hsv
herp
simplex
viru
consid
involv
diseas
antihsv
antibodi
detect
circul
serum
bd
patient
streptococcu
sangui
sangui
mainli
inhabit
mucou
membran
colon
mouth
throat
role
organ
bd
immunopathogenesi
report
sangui
detect
sera
bd
patient
highli
homolog
human
addit
demonstr
crossreact
antibodi
bd
patient
sera
sangui
recombin
peptid
sangui
also
elicit
immun
respons
human
respons
although
direct
primarili
microbi
molecul
provid
link
infect
pathogenesi
autoimmun
diseas
suggest
arthriti
multipl
sclerosi
moreov
express
certain
cytokin
upor
downregul
infect
bd
patient
exampl
inflammatori
factor
includ
tnfa
upregul
downregul
patient
bd
increas
level
ifnc
also
observ
patient
bd
data
shown
summari
annexin
suggest
specif
vascular
endotheli
cell
membran
autoantigen
bd
howev
investig
necessari
elucid
exact
role
annexin
bd
pathogenesi
longterm
clinic
monitor
effect
annexin
patient
subject
studi
serolog
criteria
evalu
assess
valid
cohort
subject
experiment
group
confirm
bd
patient
averag
age
year
rang
construct
cellchip
multifunct
cellchip
construct
base
tradit
microarray
strategi
sampl
cultur
cell
place
cover
slip
fix
paraformaldehyd
cut
fragment
cover
slip
glu
microscop
slide
immunofluoresc
assay
carri
follow
sera
bd
patient
dilut
pb
incub
slide
h
extens
wash
slide
incub
fluorescein
isothiocyanateconjug
goatanti
human
igg
competit
immunofluoresc
assay
perform
cell
line
use
serum
antiannexin
antibodyposit
bd
patient
inhibit
assay
serum
preincub
annexin
protein
h
extens
wash
slide
incub
fluorescein
isothiocyanateconjug
goatanti
human
igg
secondari
antibodi
immunohunt
beij
china
dilut
pb
h
membran
antigensbas
elisa
cell
membran
protein
extract
use
proteopreph
membran
extract
kit
sigma
mo
complet
proteas
inhibitor
cocktail
sigma
mo
extract
dispens
store
use
protein
mgml
use
coat
micropl
corn
ny
overnight
three
wash
pbst
plate
incub
goat
serum
h
sera
bd
patient
dilut
pb
ad
well
plate
incub
h
horseradishperoxidaseconjug
goat
antihuman
igg
invitrogen
ca
dilut
pb
dival
cation
incub
min
amount
bound
antibodi
quantifi
colorimetr
ad
tetramethylbenzidin
substrat
plate
read
spectrophotometr
nm
elisa
reader
tecan
hombrechtikon
switzerland
western
blot
western
blot
perform
describ
elsewher
slight
modif
cell
membran
protein
extract
use
proteopreph
membran
extract
kit
sigma
mo
complet
proteas
inhibitor
cocktail
sigma
mo
extract
dispens
store
use
cell
lysat
load
well
polyacrylamid
gel
separ
gel
transfer
onto
polyvinyliden
fluorid
membran
pvdf
merck
millipor
wash
twice
ultrapur
water
membran
block
nonfat
milk
pb
overnight
incub
bd
sera
select
due
rel
higher
optic
densiti
valu
dilut
sera
random
healthi
control
h
membran
extens
wash
four
time
pbst
buffer
remov
unbound
antibodi
final
incub
horseradishperoxidaseconjug
goat
antihuman
igg
immunohunt
beij
china
h
ecl
detect
carri
accord
product
instruct
applygen
beij
china
ingel
digest
mass
spectrometri
ingel
digest
mass
spectrometri
perform
describ
detail
elsewher
briefli
excis
gel
piec
destain
mm
nh
hco
acetonitril
dri
vacuum
centrifug
mm
dithiotreitol
mm
nh
hco
ad
cover
gel
piec
sampl
reduc
h
cool
room
temperatur
dtt
solut
replac
roughli
volum
mm
iodoacetamid
mm
nh
hco
incub
min
room
temperatur
dark
gel
piec
wash
mm
nh
hco
acetonitril
min
liquid
phase
remov
gel
piec
complet
dri
vacuum
concentr
dri
gel
piec
cover
ml
nh
hco
buffer
contain
trypsin
sigma
mo
digest
perform
overnight
excis
protein
band
identifi
use
proteom
analyz
lcmalditoftof
mass
spectromet
appli
biosystem
foster
citi
ca
mass
spectrometri
data
analyz
mascot
bioinformat
databas
search
engin
matrix
scienc
london
uk
protein
express
purif
procedur
protein
express
purif
perform
routin
method
brief
total
rna
isol
cell
use
trizol
reagent
invitrogen
ca
rtpcr
carri
accord
manufactur
instruct
fermenta
md
target
protein
overexpress
e
coli
follow
purif
recombin
protein
use
ninta
resin
qiagen
hilden
germani
concentr
protein
determin
use
bca
assay
kit
biosynthesi
biotechnolog
beij
china
purifi
recombin
protein
confirm
mass
spectrometri
western
blot
mous
antihuman
monoclon
antibodi
proteintech
chicago
il
immunoprecipit
immunoprecipit
perform
previous
describ
put
autoantigen
mg
incub
ml
mix
sera
equal
volum
three
posit
bd
patient
western
blot
detect
overnight
thereaft
protein
asepharos
bead
sigma
mo
wash
pb
ad
mix
overnight
immunoprecipit
wash
three
time
ml
pb
immunoprecipit
suspend
sampl
load
buffer
resolv
sdspage
develop
elisa
elisa
human
recombin
protein
perform
describ
previous
brief
mgml
recombin
human
annexin
sino
biolog
beij
china
use
coat
micropl
core
ny
overnight
three
wash
pbst
well
block
ml
goat
serum
h
plate
incub
ml
sera
patient
healthi
control
dilut
pb
h
three
wash
later
ml
goat
antihuman
igg
hrp
immunohunt
beij
china
ad
well
plate
incub
addit
h
follow
three
wash
ml
tetramethylbenzidin
tmb
citric
acid
na
hpo
g
hydroperitel
ml
tmb
b
mm
citric
acid
mm
edtana
g
tmbl
ad
well
plate
incub
dark
room
temperatur
min
reaction
stop
ad
ml
h
absorb
well
measur
plate
reader
nm
tecan
hombrechtikon
switzerland
immunohistochemistri
immunohistochemistri
protocol
slight
modif
previous
describ
human
umbil
veinarteri
squamou
cell
lung
cancer
kidney
cancer
tissu
sampl
treat
paraformaldehyd
overnight
fix
tissu
embed
paraffin
wax
fivemicrometerthick
paraffin
section
place
glass
slide
bake
min
incub
min
xylen
final
wash
pb
inhibit
endogen
peroxidas
section
first
incub
h
methanol
min
room
temperatur
section
boil
sodium
citratehydrochlor
acid
solut
min
incub
goat
serum
min
section
wash
pb
incub
overnight
mous
antihuman
annexin
monoclon
antibodi
proteintech
chicago
il
dilut
pb
section
wash
pb
remov
unbound
antibodi
incub
hrplabel
goat
antimous
igg
immunohunt
beij
china
section
wash
incub
dab
develop
peroxidas
activ
counterstain
perform
hematoxylin
section
dehydr
gradient
ethanol
approxim
min
concentr
place
xylen
min
observ
microscop
olympu
tokyo
japan
statist
analysi
ttest
statist
spearman
correl
coeffici
fisher
exact
text
chisquar
test
analyz
use
spss
softwar
version
il
p
valu
less
consid
signific
critic
point
posit
definit
number
higher
valu
healthi
control
mean
sd
